Cancer-specific NK cell subtypes identified
A team of researchers led by Prof. Tian Zhigang and Prof. Peng Hui from the University of Science and Technology of China (USTC) at the… Read More »Cancer-specific NK cell subtypes identified
Home » Immunotherapy »
Immunotherapy
New cancer vaccine design recruits both CD4+ and CD8+ T cells to destroy tumors
Scientists are actively pursuing a breakthrough in cancer treatment by targeting unique mutations called “neoantigens,” which enable the immune system to distinguish cancerous cells from… Read More »New cancer vaccine design recruits both CD4+ and CD8+ T cells to destroy tumors
T-Cell activator CoVac-1 shows promise in protecting cancer patients against coronavirus
Exciting news emerges for individuals with acquired or congenital immunodeficiency: A clinical phase II study conducted at University Hospital Tübingen, under the guidance of Prof.… Read More »T-Cell activator CoVac-1 shows promise in protecting cancer patients against coronavirus
New organoid-on-chip model to study on-target, off-tumor effects of T cell bispecific antibodies
An expanding array of cell and molecule-based immunotherapies holds promise for patients with tough-to-beat cancers. These therapies rally the immune system against tumors. T cell… Read More »New organoid-on-chip model to study on-target, off-tumor effects of T cell bispecific antibodies
Microneedle platform could monitor melanoma therapy response
Patients diagnosed with melanoma, a serious type of skin cancer, often face challenges with existing immunotherapies. More than 50% of patients don’t respond to current… Read More »Microneedle platform could monitor melanoma therapy response
Cancer cell fate determined within 12 hours of DNA damage
In the ongoing battle against cancer, innovative therapies like immunotherapy and targeted treatments have emerged, but traditional methods like radiation and chemotherapy still remain the… Read More »Cancer cell fate determined within 12 hours of DNA damage
Fecal microbiota transplants show promise in improving response to immunotherapy for melanoma
In a groundbreaking clinical trial published in the prestigious journal Nature Medicine, researchers from Lawson Health Research Institute, the Centre hospitalier de l’Université de Montréal… Read More »Fecal microbiota transplants show promise in improving response to immunotherapy for melanoma
New method improves treatment of aggressive brain tumors
Researchers at Uppsala University have made a significant breakthrough in the treatment of aggressive brain tumors, particularly glioblastoma. In a study published in the journal… Read More »New method improves treatment of aggressive brain tumors
- « Previous
- 1
- 2